Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Kymera Therapeutics (KYMR) Other Gross PP&E Adjustments (2019 - 2025)

Kymera Therapeutics (KYMR) has disclosed Other Gross PP&E Adjustments for 7 consecutive years, with $20.9 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 27.04% to $20.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.9 million through Dec 2025, up 27.04% year-over-year, with the annual reading at $20.9 million for FY2025, 27.04% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $20.9 million at Kymera Therapeutics, down from $22.4 million in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was $22.4 million in Q3 2025, with the low at -$33.7 million in Q1 2023.
  • Average Other Gross PP&E Adjustments over 5 years is $5.4 million, with a median of $7.6 million recorded in 2022.
  • The sharpest move saw Other Gross PP&E Adjustments tumbled 763.15% in 2023, then skyrocketed 826.25% in 2024.
  • Over 5 years, Other Gross PP&E Adjustments stood at $5.0 million in 2021, then skyrocketed by 88.68% to $9.3 million in 2022, then plummeted by 81.01% to $1.8 million in 2023, then surged by 826.25% to $16.4 million in 2024, then increased by 27.04% to $20.9 million in 2025.
  • According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at $20.9 million, $22.4 million, and $19.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.